I'm not a doctor, but I can provide some information that you could discuss with a healthcare professional. In the case of a 50-year-old female patient with a history of alcohol abuse, liver cirrhosis (Child-Pugh B), and hepatocellular carcinoma (HCC) with three lesions of 3 cm, 3 cm, and 5 cm diameter, the optimal treatment strategy would depend on various factors like liver function, overall health, and the specific characteristics of the tumors. Some possible treatment options to consider might include:

Localized treatments:
a. Radiofrequency ablation (RFA) or microwave ablation (MWA): These methods use heat to destroy cancer cells. They might be suitable for smaller tumors (usually less than 3 cm), so they may not be as effective for the 5 cm lesion.
b. Transarterial chemoembolization (TACE) or transarterial radioembolization (TARE): These procedures involve delivering chemotherapy drugs or radiation directly to the tumor via the hepatic artery. They could be considered for larger tumors or when other treatments aren't feasible.

Systemic treatments:
a. Targeted therapy: Drugs like sorafenib or lenvatinib could be considered as first-line treatment options for patients with advanced HCC.
b. Immunotherapy: Nivolumab or pembrolizumab may be used as second-line treatments or in combination with other therapies for certain patients with HCC.

Liver transplant: In some cases, patients with HCC and liver cirrhosis might be candidates for a liver transplant, if the cancer has not spread beyond the liver and they meet certain criteria.

Clinical trials: Investigating new treatment approaches through clinical trials could also be an option for some patients.

The treating physician would need to evaluate the patient's overall health, liver function, and the specific characteristics of the tumors to determine the most suitable treatment plan. It's important to consult with a healthcare professional to discuss the best course of action for this patient.